Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ABCL
#1993
AbCellera Biologics Inc. - Common Shares
6.5
4
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.31%
Monthly Change
+19.56%
6 month change
+52.09%
Year Change
+48.30%
Previous Close
6.5
2
Open
6.4
8
Low
6.4
5
High
6.6
1
Volume
626
Markets
US Stock Market
Healthcare
Biotechnology
ABCL
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
283.92 M
287.69 M
292.78 M
297.99 M
303.16 M
305.38 M
Valuation ratios
Enterprise value
3.58 B
2.34 B
1.54 B
716.78 M
908.3 M
2.07 B
Price to earnings ratio
29.79
18.98
-11.24
-5.33
-6.98
-14.68
Price to sales ratio
12.13
6.15
43.57
29.91
13.6
26.61
Price to cash flow ratio
18.61
10.77
-37.76
-7.94
-7.78
-13.77
Price to book ratio
4.44
2.42
1.44
0.82
1.06
0.54
Enterprise value to EBITDA ratio
16.37
9.93
-7.26
-2.49
-4.66
-11.35
Profitability ratios
Return on assets %
0.12
0.1
-0.1
-0.12
-0.11
-0.03
Return on equity %
0.15
0.13
-0.13
-0.15
-0.15
-0.05
Return on invested capital %
69.19
58.38
-64.66
-146.05
-95.55
-25.39
Gross margin %
100
100
100
100
100
100
Operating margin %
54.48
44.6
-623.82
-1 091.69
-288.98
-691.75
EBITDA margin %
58.34
48.61
-559.76
-998.61
-259.51
-609.51
Net margin %
40.9
32.66
-385
-564.83
-194.88
-519.12
Liquidity ratios
Quick ratio
—
—
—
—
11.23
13.89
Current ratio
7.7
8.67
7.33
9.81
11.32
14.05
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.28
0.34
0.03
0.02
0.06
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.77
0.88
-0.15
-0.37
-0.44
-0.51
EBIT per share
0.64
0.69
-0.82
-1.07
-0.73
-0.71
EBITDA per share
0.69
0.75
-0.74
-0.98
-0.65
-0.61
Total debt per share
—
—
—
—
—
—
Cash per share
1.5
1.23
0.46
2.13
1.79
1.67
Net current asset value per share
2.92
3.26
3.02
2.55
2.44
2.19
Tangible book value per share
3.22
3.92
3.98
3.59
3.24
3.1
Working capital per share
2.54
2.88
2.6
2.29
2.22
2.04
Book value per share
3.22
3.92
3.98
3.59
3.24
3.1
News
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts - TipRanks.com
Are You Looking for a Top Momentum Pick? Why AbCellera Biologics Inc. (ABCL) is a Great Choice
Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year?
Biotech Is The Rate Cut Trade In Disguise
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?
Enanta Pharmaceuticals (ENTA) Moves 5.2% Higher: Will This Strength Last?
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies
Is ABCELLERA BIOLG (ABCL) Outperforming Other Medical Stocks This Year?
AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash (NASDAQ:ABCL)
AbCellera: Q3 Hot Flashes Data Drop Aside, This Stock Is A Difficult Sell (NASDAQ:ABCL)
Wall Street Analysts Think ABCELLERA BIOLG (ABCL) Could Surge 85.59%: Read This Before Placing a Bet
AbCellera Biologics Inc. (ABCL) Presents at Jefferies Global Healthcare Conference 2026 Transcript